Anticancer Efficacy of 6-Gingerol with Paclitaxel against Wild Type of Human Breast Adenocarcinoma

Anticancer Efficacy of 6-Gingerol with Paclitaxel against Wild Type of Human Breast Adenocarcinoma

Breast cancer is one of the most common malignant neoplasms, and despite the dynamic development of anticancer therapies, 5-year survival in the metastatic stage is still less than 30%. 6-Gingerol (1-[4′-hydroxy-3′-methoxyphenyl]-5-hydroxy-3-decanone) is a substance contained in ginger, which exhibi...

Full description

Bibliographic Details
Main Authors: Kamila Wala, Wojciech Szlasa, Natalia Sauer, Paulina Kasperkiewicz-Wasilewska, Anna Szewczyk, Jolanta Saczko, Nina Rembiałkowska, Julita Kulbacka, Dagmara Baczyńska
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Molecules
Subjects:
6-gingerol
paclitaxel
breast cancer
anticancer therapy
cytostatic drug
Online Access:https://www.mdpi.com/1420-3049/27/9/2693

Internet

https://www.mdpi.com/1420-3049/27/9/2693

Similar Items